Hangzhou Genlight Neurotech Wins 2026 Global MedTech Award for Innovative Medical Device
GenLight
Innovative Medical Device Solution Provider
On June 11, at the “2026 Global MedTech Awards” selection event held in Zhongguancun, Beijing, Genlight Neurotech was honored for its continuous innovative breakthroughs in the fields of brain-computer interfaces, neuromodulation, and precision neurosurgery.“Innovative Medical Device Award”。
This award aims to recognize innovative companies and products worldwide that demonstrate original technological breakthroughs, significant clinical value, and strong potential for commercialization in the field of medical devices. GenLight’s receipt of this award fully reflects the high recognition by international industry experts of the company’s technological innovation capabilities, product development strength, and clinical application value.
Focusing on the Brain Science Track
Building Original Chinese Solutions for Neurological Disorders
As a key innovative force in the field of brain science and neuromodulation in China, GenLight Neurotech remains committed to being guided by clinical needs. It focuses on tackling core technological challenges related to major brain disorders such as epilepsy, Parkinson’s disease, and brain tumors, striving to build an innovative product ecosystem in brain science that covers “diagnosis–treatment–rehabilitation.”
Company's Independently Developed Products:
Epilcure™ Implantable Neurostimulation System
Leveraging advanced brain-computer interface technology, this system enables real-time monitoring of electroencephalographic dynamics, intelligent analysis of epileptogenic signals, and dynamic closed-loop intervention to precisely address the challenges of seizure management, offering a safe and precise new therapeutic option for patients with drug-resistant epilepsy.
LaserRO™ MRI-Guided Semiconductor Laser Therapy System
Featuring an innovative dual-wavelength synergistic laser ablation technology integrated with real-time MRI monitoring, it achieves targeted and precise ablation of intracranial lesions. Centered on minimally invasive and precise intervention, the product is dedicated to enhancing treatment safety and efficiency, offering a new pathway for minimally invasive diagnosis and therapy in neurosurgery.
As of now, the company has established an intellectual property portfolio covering brain-computer interfaces, neuromodulation, neurophysiology, and precision neurosurgical equipment, and has built a comprehensive innovation system encompassing product development, clinical validation, regulatory submission, and industrial commercialization.
Building a New Ecosystem for the Brain Science Industry: Looking to the Future
Currently, brain science and brain-computer interfaces have become important strategic directions in global technological competition and medical innovation. With the rapid development of artificial intelligence, neural engineering, advanced sensors, and precision medicine technologies, the brain science industry is ushering in unprecedented opportunities for development.
GenLight Neurotech will take this award as a new starting point to further strengthen global collaboration and technological innovation, contributing Chinese wisdom and solutions to advancing the brain science industry and improving the diagnosis and treatment of neurological disorders.
